Sign in
KALA Stock Price, Chart, Stats & News
KALA BIO, Inc.
Save
55.92M
Market cap
–
Current P/E
–
Forward P/E
KALA chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -3.15% |
Operating margin | -15055.91% |
Pretax margin | -14110.63% |
Net margin | -14110.63% |
Effective tax rate | – |
ROA | -143.24% |
ROE | -2323.94% |
D/E | -3.58x |
Interest coverage ratio | -8.45x |
KALA valuation
P/E | – |
P/S | 15.17x |
P/B | -0.14x |
P/CF | -0.04x |
P/FCF | -0.12x |
P/OCF | -0.04x |
PEG | -0.00x |
EV multiple | 0.20x |
About
Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanoparticle technology, specifically mucus penetrating particles (MPPs). Initially, their focus for these treatments is directed towards ophthalmic diseases.
Similar securities
Based on sector and market capitalization
Report issue